Irreversible coma, ergotamine, and ritonavir

11Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We report the first case in the medical literature (to our knowledge) of a patient with human immunodeficiency virus infection who was being treated with ritonavir and developed signs of severe vascular involvement and irreversible coma after the administration of 3 mg of ergotamine tartrate.

Cite

CITATION STYLE

APA

Rey, C. P., Yebra, M., Borrallo, M., Vega, A., Ramos, A., & Montero, M. C. (2003). Irreversible coma, ergotamine, and ritonavir. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 37(5), e72-73. https://doi.org/10.1086/376636

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free